Asthma, derived from the Greek word ἆσθμα (âsthma) which means “panting” (Murray, 2010), is a variable, long-term condition that affects over 350 million children, adolescents and adults worldwide (Meghji et al., 2021), and 250,000 deaths per year are attributed to the disease. It is expected that this amount will reach more than 400 million by 2025 (Masoli et al., 2004). From a medical standpoint, asthma is a complex, heterogenous and chronic inflammatory disease that affects the airways of the lower respiratory system. The constriction of the airways varies between individuals and is caused by excessive T-helper type 2 (Th-2) cell responses and specific immunoglobulin E (IgE) antibodies production, which trigger inflammation-related increases in bronchial muscle tone (Kuruvilla et al., 2019; Ray et al., 2021). The mechanisms causing asthma development remain not fully understood but are believed to involve a co-occurrence of inflammation and airway remodelling, ultimately leading to bronchial hyperresponsiveness. Sensitizer-induced asthma often presents with elevated eosinophil levels in blood and sputum, alongside activation of T-helper type 2 (Th2) cells. This activation triggers the release of inflammatory cytokines (i.a., IL-4, IL-5, and IL-13) and promotes IgE synthesis. Occupational exposures are a common cause of sensitizer-induced asthma (Clausen et al., 2020; Tarlo and Lemiere, 2014). A plethora of factors cause the disease, provoke asthma exacerbations, and contribute to asthma disease progression (Kuruvilla et al., 2019). The incidence of asthma depends on factors including age, geographical location, socioeconomic status, and race. Moreover, the factors that contribute to the progression to asthma from viral- and allergen-induced respiratory symptoms are largely unexplored. The primary symptoms of asthma are coughing, wheezing, and dyspnea, with additional signs encompassing bronchospasm, chest tightness, mucous edema, and sputum production. Asthma symptoms can vary in intensity and severity, which can affect daily activities (Clearie et al., 2010).

Acute bronchial and laryngeal symptoms development is influenced by hereditary and external factors, such as air pollution, tobacco smoke, viral infections, and exposure to allergens. Certain medications, such as angiotensin-converting enzyme inhibitors, aspirin, and non-steroidal anti-inflammatory drugs (NSAIDs), may also cause asthma (Covar et al., 2005). Other factors that can trigger asthma symptoms include common substances of animal and vegetable origin, as well as substances that cause immune responses. However, the most significant factors that produce asthma symptoms are house dust mites, animal dander (fragments of fur or feathers), cockroaches, fungi, mould, yeast, and pollen allergens (Voisin et al., 2010; Joyner et al., 2006). The development of asthma is influenced by both genetic predispositions and environmental factors. Genetic factors involve immune responses to small doses of allergens, which can cause oversecretion of IgE antibodies against these allergens (allergic sensitization). In addition, blood eosinophilia (elevated blood eosinophil counts) correlates with airway eosinophilic inflammation in patients with asthma (Pignatti et al., 2018). The latter pathological condition is stimulated by the adaptive and/or innate immune system: Th-2 cells and type-2 innate lymphoid cells (ILC2s), respectively. Thus, multiple asthma-associated single nucleotide polymorphisms (SNPs) may constitute genetic susceptibility to eosinophilic asthma (El-Husseini et al., 2023).

In recent years many scientists have shown the influence of chlorine disinfectants and risks of new-onset allergic sensitization and airway inflammation after early age swimming in chlorinated pools. To be triggered, these interactions between pool chlorine and atopy require prior sensitization to aeroallergens, as well as cumulative exposure to chlorinated pools over a period of at least a few years (Voisin et al., 2014). Although chemical exposures from disinfectant products used on swimming pools often go unnoticed or unrecognized, they have been linked to asthma-related symptoms and exacerbations. Individuals with atopy are hyperallergic to substances that are otherwise harmless to the healthy population. While some people with asthma rarely experience symptoms, others may react frequently and readily and experience persistent symptoms. Clinical research indicates that the risk of asthma is 48%–79% higher in genetically predisposed individuals (El-Husseini et al., 2023). Unfortunately, both maternal and paternal disease state affects offspring disease, and based on individual studies, maternal asthma is the more potent contributor (Guilbert et al., 2007). For example, children of asthmatic or atopic parents have a 3 to 6 times greater risk of developing asthma (Lim et al., 2010). In recent years, there has also been observed a correlation between obesity and an increased risk of asthma (Beuther, 2010; Holguin and Fitzpatrick, 2010). For example, Sutherland et al. (2008) found in 30 asthmatic women before and after methacholine provocation that the increase in functional residual capacity and decrease in inspiratory capacity were significantly greater in obese asthmatic women (p < 0.001 and p = 0.003, respectively). Additionally, some genetic variants may only cause asthma when combined with specific environmental exposures (Martinez, 2007). Genetic predispositions may contribute to the improper function of beta-2-adrenergic receptors (ADRB2, also known as β2-AR), which can reduce their activity and cause disturbed tonicity of bronchial muscles due to the dominance of the parasympathetic nervous system controlling muscle contraction (Liang et al., 2014).

In recent years, concerns have been raised regarding the potential negative effects of water disinfectants used in swimming pools on the respiratory system and the development of hypersensitive reactions among regular swimmers (Manasfi et al., 2017; Yang et al., 2018).

A high frequency of upper and lower airway respiratory symptoms has been reported in competitive athletes and school children attending regularly to the swimming pools (Hsia, 2004; Belda et al., 2008; Momas et al., 1993). These results are summarised in Table 1. Several studies have shown that nasal symptoms were highly frequently in swimmers regularly attending pools, mainly 7%–74% of swimmers complaining of chronic rhinitis symptoms (Murray, 2010; Deitmer and Scheffler, 1990; Gelardi et al., 2012). Moreover, even 44% of young competitive swimmers with rhinitis had a pre-existing allergic component (Gelardi et al., 2012). Given the relatively high prevalence of viral infections in competitive swimmers, nasal symptoms may be caused by an acute viral infection or a post-infection condition (Gleeson et al., 2002; Moreira et al., 2009; Gleeson and Pyne, 2016). From a general perspective, the major upper respiratory symptoms reported are itching, sneezing, nasal obstruction, rhinorrhoea and symptoms associated with sinusitis (Deitmer and Scheffler, 1990; Potts, 1994; Gelardi et al., 2012).

Swimmers also report ocular symptoms, throat pain and headache (Potts, 1994; Levesque et al., 2006). Both upper and lower airway respiratory symptoms may have a noxious influence on swimmers performance. Zwick et al. (1990) reported that 79% of the swimmers training 27–37 h per week presented various upper and lower respiratory symptoms compared with 21% of controls. Helenius et al. (2002) observed swimming-induced lower airway respiratory symptoms in 57% of the 42 Finnish National Team swimmers. Both studies of Turcotte et al. (2003) and Levesque et al. (2006) showed a clear predominance of symptoms such as cough, wheezing, breathlessness and chest congestion. Interestingly, the symptoms of exercise-induced breathlessness shown in the study by Turcotte et al. (2003) were more often reported by female (42.7%) than male athletes (29.6%, p = 0.0004). Seys et al. (2015a) and Bernard et al. (2006) reported in their research that the main symptoms observed were: cough (46% and 18%, respectively) and breathlessness (49% and 7%, respectively).

However, Deitmer and Scheffler (1990) observed only upper respiratory symptoms such as sneezing, itching, nasal obstruction and sinusitis while there were no symptoms as rhinorrhoea, nasal obstruction or sinusitis reported by Potts (1994). Although Potts (1994) noticed that among various symptoms we can indicate major ones, as, for example,: sneezing/itching (45%), breathlessness (39%), cough (36%), wheezing (36%), and/or headache (36%). Päivinen et al. (2010) investigated that 43% of top Finnish swimmers reported breathlessness and 27% submitted cough. On the other hand, Font-Ribera et al. (2009) showed that among 3223 participants, 35% developed rhinorrhea and about 35% had eye irritation, while another study showed that among 2758 participants, 39% developed wheezing and 28% rhinorrhea (Font-Ribera et al., 2010).

Respiratory symptoms are not only frequently reported by elite swimmers, but also by children and youths regularly attending to the swimming pools. However, Paciência et al. (2021), Langdeau et al. (2000), Gelardi et al. (2012) and Momas et al. (1993) observed mainly rhinorrhoea. Zaccarin et al. (2022) conducted a study on young Italian competitive swimmers, revealing a predominance of upper respiratory symptoms, with 47% experiencing nasal congestion/rhinorrhea and 62% reporting sneezing. Additionally, the most frequently observed lower respiratory issues included difficulty breathing (25%), chest tightness (19%), wheezing (17%), and coughing (42%) (Seys et al., 2015b). The most frequently reported symptoms of lower respiratory system were cough and asthma-like symptoms such as breathlessness, wheezing and chest tightness, whereas out of upper tract were presented mostly throat irritation, rhinorrhea and sneezing/itching. The most frequent non-respiratory tract symptoms were headache and eye irritation.

Swimmers have increased exposure to chlorine and other chemicals, and this exposure can induce airway sensitization (Pigakis et al., 2022). Chlorination by-products (CBPs) have a strong oxidising potential, and exposure may contribute to airway damage, causing barrier disruption (Musch et al., 2006; Bernard, 2007).

A summary of the studies describing short- and long-term changes in respiratory biomarkers are presented in Table 2.

The World Health Organization (WHO) recommends adequate water disinfection to prevent microbial proliferation in swimming pools. Chlorine-based disinfectants (chlorine gas, sodium or calcium hypochlorite, di- or trichloroisocyanurates) are commonly used in indoor pools due to their effectiveness and lower relative cost, despite possibly leading to unwanted effects (Couto et al., 2021). Although there are several disinfection options available, such as bromine, ozone, copper-silver, UV irradiation, electrochemically generated mixed oxidants, and UV/hydrogen peroxide (Figure 1), chlorination still remains the most widely used method to disinfect pool water (Westerlund et al., 2019; Couto et al., 2021).

When reacting with organic or inorganic matter (such as urea, sweat, dandruff, and skin flakes) chlorine produces chlorinated oxidants or derivatives (CBPs with high redox potentials) which can be inhaled, ingested or absorbed via the skin (which may represent a source of muco-cutaneous symptoms). These include monochloramines (NH₂Cl), dichloramines (NHCl₂) and trichloramines (N₂Cl₃), as well as organohalogen compounds such as trihalogenomethanes (THM) and haloacetic acid (HAA) (see Figure 1; Cavaleiro et al., 2018; Jacobs et al., 2007; Kanikowska et al., 2018).

Scientific research has demonstrated that swimming pool water can possess mutagenic properties, with varying degrees of potency reported in different studies. Many disinfection by-products (DBPs) have carcinogenic and genotoxic properties, and exposure to DBPs have been linked to reproductive and neurotoxic adverse effects in animal studies. Human epidemiological studies have shown that exposure to DBPs can increase the likelihood of respiratory adverse effects and bladder cancer, although the association between DBPs and other health effects is still uncertain (Manasfi et al., 2017). Epidemiological data about the risk of cancer are still controversial. However, numerous publications highlight a toxic risk, especially the risk of allergy and respiratory symptoms, for babies and elite swimmers (Florentin et al., 2011).

Trichloramine (NCl₃), an inorganic chloramine (0.02 mg/L in water as Cl₂), is considered one of the most toxic substances–an easily volatile substance with a characteristic odour that occurs as DBP in the air of chlorinated indoor swimming pools from reactions of nitrogenous compounds with chlorine (Schmalz et al., 2011). Trichloramine in higher concentrations causes acute irritation of the respiratory tract mucosa (Bernard et al., 2005). Seys et al. (2015a) described a situation in which, as a result of an accidental increase in the concentration of trichloramine in the air, people in indoor swimming pools complained of coughing, shortness of breath, watery eyes and nasal congestion. Twenty-two of the 26 subjects were found to have bronchial hyperreactivity during a histamine provocation test (Kanikowska et al., 2018).

The level of CBPs above the water surface is influenced by factors such as chlorine dosage, air temperature, pool area ventilation, and swimmer/bather load. Swimmers are exposed to these by-products when inhaling air and aerosols right above the water surface, where is their highest concentration (Schmalz et al., 2011). In regular swimmers, at a ventilation rate of 22 L/min, there is a switch from nasal to mouth breathing. Consequently, the air inhaled undergoes less filtration by the nasal cavity and CBPs are able to travel further into the lungs (Lomax, 2016; Kanikowska et al., 2018). A study by Voisin et al. (2014) involving 196 preschool-aged children found that regular swimming in a pool with chlorinated water before the age of three was associated with higher serum allergen-specific IgE (sIgE) antibody concentrations for house dust mites and higher nitric oxide concentrations in exhaled air between the ages of five and seven, a risk factor for the development of bronchial asthma and rhinitis. A large Swedish population-based study involving 1,652 children aged 11–12 found that children who visited the pool more than once a week were more likely to develop bronchial asthma than those who swam less often. The risk was higher only in children who were allergic to aeroallergens, as confirmed by prick skin tests (Andersson et al., 2015). Even in adults who swam recreationally, a higher incidence of new-onset asthma was observed in a study involving 1136 adults, and the development of the disease was related to the cumulative number of hours spent in indoor pools over a lifetime (Ferrari et al., 2011).

In a study by Carbonelle et al. (2002) transient bronchial epithelial damage was observed after an hour-long stay in an environment containing chlorine compounds in children and adults who swam recreationally, as well as in those who passively inhaled air containing chlorine compounds. Such recurrent damage is most likely related to oxidative stress and causes inflammation, which then leads to the development of sensitization to aeroallergens. In most competitive swimmers, cessation of professional swimming training results in a decrease in bronchial hyperresponsiveness and airway inflammation. However, it is still not known whether this is fully reversible phenomenon, and over what period of time the decrease occurs (Bougault et al., 2011). Sun et al. (2022) presented a study that included 2359 adolescents aged 12–19 years with measured blood concentrations of chloroform (trichloromethane, TCM; bromodichloromethane, BDCM; dibromochloromethane, DBCM; and bromoform: tribromomethane, TBM) from the National Health and Nutrition Examination Survey 2005–2012. The results have shown that blood DBCM concentrations were associated with a higher risk of ever asthma among all adolescents. They also found positive relationships between blood brominated THM concentrations and risk of ever asthma and between blood DBCM and brominated THM concentrations and risk of current asthma among adolescents with tobacco smoke exposure. However, in a study performed by Valeriani et al. (2017), different conclusions have been made. Their systematic review and meta-analysis led to the assumption that swimming in childhood does not increase the likelihood of doctor-diagnosed asthma. Based on this meta-analysis review, the association of the disease with indoor pool attendance is still unclear. There are other potentially hazardous compounds from pharmaceuticals and personal care products (PPCPs) that are present in swimming pools (Celeiro et al., 2018). A few toxicological studies suggest that some organic UV filters have significant estrogenic and antithyroid effects (Kinnberg et al., 2015; Schmutzler et al., 2007) and they can bioaccumulate. Unfortunately, CBDs may react with the organic UV filters and may contribute to the formation of chlorinated DBPs (Santos et al., 2012). Therefore, considering the potential harmful effects of UV filters in swimming pool waters, the development of effective processes that lead to a complete removal of UV filters is necessary.

Not only the pool water contains harmful substances causing pathological mechanisms, but also the air in the swimming pool is saturated with nitrogen trichloride, which causes so-called occupational asthma in water rescuers and swimming instructors who spend long hours at the pool inhaling multiple substances (Cavaleiro et al., 2018). Thickett et al. (2002) presented three well-documented cases of occupational asthma in swimming-pool workers. Two of these individuals had a positive bronchial provocation test to chloramine in the laboratory, there is little doubt that these people had occupational asthma. However, the exact cause of the asthma in these individuals is still unknown. While it may be due to immunological sensitization, the fact that they reacted to low levels of trichloramine suggests that it may not be a purely irritant effect. A pure irritant effect was, therefore, considered less likely as the subjects had no increased bronchial reactivity to histamine. Irritant-induced asthma caused by chronic low-level exposure to irritant agents is a controversial topic with limited epidemiological and experimental support.

There are no population-based studies comparing the impact of using swimming pools with alternative water disinfection agents: ozone, UV radiation, bromine and salt, as well as silver and copper ions. The optimal microbiological and chemical method is ozonation of water, but due to its higher cost, this method is rarely used, nor is it completely free of toxic by-products. When using pools with chlorinated water, air circulation is crucial, as it disperses toxic compounds suspended in the air. It is also important to use the smallest effective amount of chlorine disinfectant, for pool users to wash their bodies thoroughly before swimming, and to use swimming caps to limit the delivery of organic compounds into the pool. Asthma treatment in competitive swimmers should be based on prevention of exposure to chlorine substances. The level of nitrogen trichloride should be constantly monitored, fresh air supply should be ensured and the proper air and water temperature should be maintained (Belda et al., 2008; Cavaleiro et al., 2018; Kanikowska et al., 2018). Some recent advances in chlorination and DBPs, their types, DBPs guidelines, and methods for removing DBPs have been described (Gani et al., 2024). Two basic approaches were identified to mitigate the risks associated with the effects of DBPs on the human body: [1] reducing DBP formation by the use of chlorine dioxide (ClO₂), which has a higher oxidation potential than chlorine and can therefore more effectively oxidize organic matter in water; [2] the use of monochloramine, a less reactive and less volatile form of chlorine, that can be more stable in water and reduce DBP formation. These and other advances in chlorine applications can contribute to safer and more effective water treatment.

Spirometry is the main respiratory function assessment test, as a standardized and reproducible method for estimating the respiratory mechanism and pulmonary ventilation (Lazovic-Popovic et al., 2016). There have been several studies conducted to examine the effects of swimming on spirometry parameters. For instance, a study conducted by Wicher et al. (2010) focused on children and adolescents with mild persistent asthma. The participants were divided into two groups: a swimming group and a control group. Both groups received standard asthma medication, while the swimming group also underwent a swim training program consisting of 2 weeks⁻¹ classes over a 3-month period. The results showed that the participants in the swimming group experienced a significant improvement in bronchial hyperresponsiveness compared to the control group. This was measured by an increase in the provocative concentration of methacholine causing a 20% fall in forced expiratory volume in 1 s (FEV1) values. Additionally, the swimming group showed improvement in the elastic recoil of the chest wall.

Another interesting study conducted systematic review and meta-analysis to examine the effects of physical activity on lung function and quality of life (QoL) in asthmatic children (Jing et al., 2023). Randomised controlled trials were included and two reviewers independently conducted the inclusion screening, data extraction and bias assessment. A total of 9 studies were included in this review after 3,919 articles were screened. The authors found that physical activity significantly improved forced vital capacity (FVC) and forced expiratory flow between 25% and 75% of forced vital capacity (FEF25-75), which are measures of lung function. However, there was no significant improvement in FEV1 or fractional exhaled nitric oxide (FeNO), which indicates airway inflammation. Physical activity also had a positive impact on the QoL of asthmatic children.

Various studies using spirometry tests revealed that competitive swimmers had a mean baseline FEV1 and FVC of approx. 110% of predicted values. Airway obstruction was observed in 12% of the swimmers included in the study. Interestingly, with the exception of two individuals, all swimmers exhibiting airway obstruction were males. In addition, swimmers who swam a distance of more than 2,000 m reported significantly more respiratory symptoms compared to the other subjects (Päivinen et al., 2010; Päivinen et al., 2021).

In the study of Fiks et al. (2012) 1,116 young swimmers between 8 and 17 years of age completed the questionnaire and underwent spirometry at rest. Among all of the participants, 254 individuals (22.7%) were identified to have airflow obstruction (FEV1/FVC <80%).

In general, competitive swimmers achieve larger lung volumes and higher functional cardiorespiratory system capacity compared to other athletes (Doherty and Dimitriou, 1997). However, no large-scale studies have been conducted to analyse in detail the effects of specific sports on pulmonary function, including asthma. Recently, the prospective study conducted by Malewska-Kaczmarek et al. (2022) examined the impact of different types of physical activity, including swimming. The research involved a group of Polish Caucasian children who were involved in sports activities at schools and clubs. The study considered a range of sports starting with football, horse riding, tennis, dance, athletics, cycling, martial arts, gymnastics, floorball, basketball, volleyball, handball, and swimming. Children with a diagnosis of chronic respiratory system diseases other than asthma were excluded, as were those who did not cooperate during the lung tests or had contraindications for the planned tests. Additionally, children with asthma who were undergoing treatment were asked to refrain from using long-acting beta-2 mimetics (LABA) for 24 h before their scheduled visit.

Spirometry was performed to measure lung function, a pulmonary resistance test, a measurement of fractional exhaled nitric oxide (FeNO) concentration to assess airway inflammation, and a standardised exercise test to evaluate response to physical exertion. They also performed a treadmill exercise challenge, and the parameter analysed was the percentage of FEV1, which represents the difference between the highest and lowest FEV1 achieved before and after the exercise challenge. The findings showed that swimmers had the highest FEV1 values, followed by indoor athletes. This suggests that swimming and certain types of physical activities can positively impact lung capacity, with swimmers exhibiting the highest values compared to other athletes (Lazovic-Popivic et al., 2016). Overall, these studies indicate that swimming and physical activity in general can have beneficial effects on spirometry parameters, such as bronchial hyperresponsiveness, lung function (FVC and FEF25-75), and QoL in asthmatic children. However, more research is needed to determine the specific effects of swimming compared to other types of physical activity on lung capacity and asthma control. The data on the differences in the risk of respiratory dysfunction according to the level of sports training are also of interest. Competitive swimmers who had the highest exposure to swimming pool environments, reported significantly more respiratory symptoms compared to fitness and occasional swimmers. Overall, 18% of the swimmers studied reported respiratory symptoms, with competitive swimmers being the most affected group. Moreover, competitive swimmers reported three times as many respiratory symptoms as other activity groups in swimming halls (Päivinen, et al., 2021).

It is currently accepted that strenuous (76%–95% HR_max; >6 MET) exercise increases the risk of developing asthma, assuming a dose-response relationship between physical activity and EIA/EIB risk (see Figure 2). This relationship is curvilinear (“U”-shaped curve), showing that moderate-intensity exercise (64%–75% HR_max; three to six MET) results in a lower risk of asthma compared to low-intensity exercise (40%–63% HR_max; <3 MET) and high-intensity exercise (especially endurance and interval training) (Del Giacco et al., 2015).

According to the study of Carlsen et al. (2008) asthma and allergies are becoming increasingly prevalent issues among actively competing athletes, particularly in elite endurance-trained athletes, where EIA or EIB is frequently reported. The prevalence of asthma and bronchial hyperresponsiveness (BHR) is significantly higher in endurance-trained athletes in sports such as swimming, cycling and triathlon. According to Fitch et al. (2012), over 17% of Olympic swimmers and 13% of synchronised swimmers have asthma and/or BHR. Additionally, other forms of pollution can also impact athletic performance. Therefore, epidemiological studies in athletes provide substantial indirect evidence suggesting that various factors such as pollen exposure in summer athletes, cold air and respiratory infections in skiers, chlorine exposure in swimmers, and fine particles in ice rinks can adversely affect respiratory health in competitive athletes.

Heavy endurance swimming training, similarly to high-intensity interval training, especially under adverse conditions, stresses the airway mucosa, leading to inflammatory changes (i.e., higher levels of eosinophils and FeNO) as observed in induced sputum in competitive swimmers (Helenius et al., 1998). Consequently, the combination of intense and repeated physical endurance training over extended periods, along with suboptimal environmental conditions, may contribute to the development of asthma and BHR in elite athletes. Larsson’s et al. (1998) study demonstrated that cold air inhalation increased the number of inflammatory cells in bronchoalveolar lavage. In children, Bernard et al. (2003) found a correlation between the time spent in swimming pools during early childhood and the development of asthma, as well as signs of lung involvement indicated by increased serum levels of surfactant proteins.

Bronchial asthma is a chronic inflammatory condition of the lower airways characterised by breathlessness, bronchial obstruction and coughing. Various combinations of the involved factors determine and modify the final clinical phenotype/endotype of asthma (Jesenak et al., 2017). Exercise-induced symptoms are commonly referred to as transient bronchoconstriction (Jayasinghe et al., 2015). The best way to verify the influence of the bronchodilators on the respiratory system is to examine the swimmers who systematically attended the swimming pool, especially professional long-distance swimmers. Inhaled short-acting β2-agonists (SABAs) are frequently needed and strongly suggested as pre-treatment before competition. If insufficient, long-acting β2-agonists (LABAs) and leukotriene antagonists may be added (Carlsen et al., 2008). Based on current anti-doping regulations, competitive swimmers are permitted to use specific inhaled β2-adrenergic agonists, both short- and long-acting, such as formoterol, salbutamol, salmeterol, terbutaline, and inhaled corticosteroids (ICS), in dosages precisely determined in the Therapeutic Use Exemptions (TUEs). In cases of properly treated and controlled asthma, these substances, at the dosages defined by World Anti-Doping Agency (WADA), effectively suppress the symptoms of the disease without posing a risk to the swimmer’s health (Courteix et al., 1997; Bougault et al., 2009; Mountjoy et al., 2015). The vast majority of studies show that the use of the aforementioned substances by healthy non-asthmatic athletes does not increase physical performance (e.g., endurance and speed) (Zwick et al., 1990; Momas et al., 1993; Murray, 2010), with the exception of oral short-term administration of salbutamol, which enhances voluntary muscle strength in man (Martineau et al., 1992). On the contrary, recent systematic review and meta-analysis of randomized controlled trials showed that non-asthmatic subjects can improve sprint and strength performance by using β2-adrenergic agonists (Riiser et al., 2020). However, it should be noted that the improvement was observed for maximal physical performance lasting 1 min or shorter.

From a physiological standpoint, there is no justification for including β2-adrenergic agonists on the WADA Prohibited List, as there is no strong evidence to suggest ergogenic (performance-enhancing) effects in competitive athletes, such as improved endurance and speed, unless they have asthma. To summarize, the most up-to-date systematic reviews and meta-analyses demonstrated that β2-adrenergic agonists do not affect sports performance in healthy athletes (including swimmers) regardless of type, dose, administration route, duration of treatment or the performance level of the participants.